[ad_1]
The French Health Authority gave the green light to resume vaccination “without delay” with the AstraZeneca vaccine, but recommended that it be assigned to people 55 and older, in a position published on Friday.
And the country’s highest health authority added that this matter was decided because the serious and rare cases of bleeding disorders that caused the suspension of the use of this vaccine in several European countries, appeared only in people under 55 years of age.
He added that three such cases were registered in France.
After the controversy that affected the AstraZeneca vaccine after several countries suspended its use due to fears related to causing blood clots, the European Medicines Agency came out with good news about the vaccine, to settle the controversy and confirm that it is safe and effective.
On Thursday, he said, there is no evidence of a link between the AstraZeneca vaccine and blood clots, emphasizing that the final conclusion confirms that it is effective and safe.
He also added: “The benefits of the AstraZeneca vaccine outweigh any potential secondary risks,” the Al-Arabiya correspondent reported.
This came hours after the Medicines and Healthcare Products Regulatory Agency confirmed in Britain earlier today that the evidence does not indicate that the AstraZeneca vaccine to prevent Covid-19 causes blood clots, but indicated that it is is conducting research on a rare and special type of blood clot in the veins of the brain.
